Clinical Trial

FearLess in NeuroOncology

Recruiting
View on ClinicalTrials.gov →
Summary
The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-05-16; most recent amendment 2025-09-02.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Trial Details
NCT Number NCT06989086
Lead Sponsor Virginia Commonwealth University
Collaborators: National Cancer Institute (NCI), National Brain Tumor Society
Conditions Primary Malignant Brain Tumor, Glioblastoma (GBM), Astrocytoma, Oligodendroglioma, Caregiver
Enrollment 112 participants
Start Date 2025-06-24
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-09